Swift Medical, a leader in digital wound care innovation, has announced the launch of its new Skin & Wound 2 platform. This platform is recognized as the gold standard in the digital wound care segment that Swift helped establish, with over 50 million patient assessments conducted in various healthcare settings, including home health, ambulatory, acute, and skilled nursing facilities.
Key Highlights
- Clinically Validated Innovations
- With over 22 peer-reviewed publications, Swift Medical has demonstrated a commitment to clinically validating its innovations, showcasing proven outcomes in accuracy, equitable AI, and improved healing rates.
- Empowering Clinicians
- “Skin & Wound 2 demonstrates our continued commitment to empowering clinicians with the most advanced tools available, enabling superior wound care outcomes,” said Dwayne Sansone, CEO of Swift Medical.
- The platform embodies Swift’s mission to “Heal Our World Faster” by utilizing generative AI for highly accurate diagnostics, ensuring equitable care for every patient, regardless of their background.
- Advanced Features and Integration
- Built with the evolving healthcare landscape in mind, Skin & Wound 2 leverages Swift’s patented AI technologies and incorporates the latest FHIR standards.
- The platform integrates seamlessly with premier EMR systems like Homecare Homebase, offering best-in-class imaging and documentation capabilities.
- It boasts a modern user interface designed for expedited evaluations, achieving the highest level of submillimeter accuracy.
- Collaborative Partnerships
- Scott Pattillo, Chief Strategy Officer of Homecare Homebase, emphasized the strength of their collaboration with Swift: “Our partnership provides customers with the best digital wound care solution in the market to help patients heal faster.”
- Remarkable Growth and Scalability
- In 2024, Swift Medical surpassed 600,000 wound care evaluations in a single month, facilitated by over 21,000 clinicians.
- Skin & Wound 2 supports enterprise scalability without sacrificing quality, paving the way for rapid deployment of new features and groundbreaking capabilities planned for the coming year.
The launch of the Skin & Wound 2 platform marks a significant advancement in digital wound care, enhancing the tools available to clinicians and ensuring accurate, equitable treatment for patients. Swift Medical’s dedication to leveraging AI and fostering collaborative partnerships positions the company as a leader in transforming wound care and improving patient outcomes across diverse healthcare settings.